Analystreport

Nightstar Therapeutics (NASDAQ: NITE) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $31.00 price target on the stock.

NIGHTSTAR THERAPEUTICS PLC AMERICAN DEPOSITARY SHA  (NITE) 
Last nightstar therapeutics plc american depositary sha earnings: 11/13 01:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.nightstartx.com/investor-relations